查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701272

週边神经损伤市场规模、份额、趋势分析报告：按产品、手术、应用、地区、细分市场预测，2025-2030

Peripheral Nerve Injury Market Size, Share & Trends Analysis Report By Product (Nerve Conduit, Nerve Protector), By Surgery (Direct Nerve Repair, Nerve Grafting, Stem Cell Therapy), By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

週边神经损伤市场的成长和趋势：

根据Grand View Research, Inc.的最新报告，全球週边神经损伤市场规模预计到2030年将达到25.8亿美元，预计2025年至2030年期间的复合年增长率为7.80%。

COVID-19 正在对市场产生不利影响，直接影响需求和生产，扰乱供应链并增加企业的财务负担。在疫情期间，许多手术被例行性推迟和/或取消，以防止 COVID-19 的传播。受灾最严重的国家包括美国、俄罗斯、印度、巴西、法国、英国、义大利和西班牙，神经外科手术量下降了55%。

此外，由于全国封锁，生物材料的製造活动、供应链、交货计划和销售都受到干扰。展望未来，随着产业参与者采用更新、更好的技术，预计该产业将在预测期内实现成长。例如，2022 年 5 月，Axogen, Inc. 揭露了 Axogen 的 RECON 临床试验的主要结果，该试验比较了 Conduit 与 Avance 神经移植在数位神经损伤中的应用，Axogen, Inc. 是 PNI 突破性手术解决方案的营销和开发领域的全球先驱。在第 3 阶段关键研究中，实现了恢復静态两点辨别定义的感觉功能的主要目标，安全性与先前报告的资料相当。这些资讯可能有助于该公司在 2023 年下半年提交生技药品核准申请 (BLA)。

週边神经损伤市场报告重点

  • 神经导管预计将引领市场，2024 年的收入份额将超过 64.30%。
  • 直接神经修復领域预计将引领市场，到 2024 年将占全球收入的 53.26% 以上。
  • 上肢部分在 2024 年占据了最大的市场占有率，预计在 2025 年至 2030 年期间将以最快的复合年增长率进一步增长。
  • 2024 年，北美占据市场的最大收益占有率，超过 30.43%。

目录

第一章调查方法与范围

第二章执行摘要

3. 週边神经损伤市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 週边神经损伤市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章週边神经损伤市场：产品估计与趋势分析

  • 定义和范围
  • 2024年及2030年的产品市场占有率
  • 细分仪表板
  • 週边神经损伤市场（按产品）展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 神经导管
    • 神经保护剂
    • 神经连接器
    • 神经绷带

第五章週边神经损伤市场：手术估计与趋势分析

  • 定义和范围
  • 2024年及2030年外科手术市场占有率
  • 细分仪表板
  • 週边神经损伤市场：外科手术展望
  • 2018年至2030年市场规模、预测及趋势分析
    • 直接神经修復
    • 神经移植
    • 干细胞疗法

第六章週边神经损伤市场：应用评估与趋势分析

  • 定义和范围
  • 2024 年和 2030 年应用市场占有率
  • 细分仪表板
  • 週边神经损伤市场：应用前景
  • 2018年至2030年市场规模、预测及趋势分析
    • 上肢
    • 下肢

第七章週边神经损伤市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 区域市场占有率和主要参与者（2024年）
  • 2018年至2030年市场应用、预测与趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 主要客户
    • 主要企业市场占有率分析（2024年）
    • AxoGen, Inc.
    • Stryker
    • Baxter International, Inc.
    • Polyganics BV
    • Integra LifeSciences
    • Renerva, LLC.
    • Newrotex
    • Toyobo Co., Ltd.
    • Orthocell Ltd
Product Code: GVR-4-68039-957-2

Peripheral Nerve Injury Market Growth & Trends:

The global peripheral nerve injury market size is estimated to reach USD 2.58 billion by 2030, registering to grow at a CAGR of 7.80% from 2025 to 2030 according to a new report by Grand View Research, Inc. COVID-19 has had a negative impact on the market, affecting the demand and production directly, disrupting the supply chain, and increasing the financial burden on businesses. During the pandemic, a number of surgeries were regularly postponed and/or canceled to prevent the spread of COVID-19. Neurosurgical procedures decreased by 55% in the worst-hit countries, including the U.S., Russia, India, Brazil, France, the U.K., Italy, and Spain.

Furthermore, manufacturing activities, supply chain, delivery schedules, and sale of biomaterials were disrupted due to nationwide lockdowns. Moving forward, as industry players are introducing new and better technologies, the industry is expected to grow over the forecast period. For instance, in May 2022, the topline results of Clinical Study Axogen's RECON comparing conduits to Avance Nerve Graft in digital nerve injuries were disclosed by Axogen, Inc., a global pioneer in marketing and developing revolutionary surgical solutions for PNIs. The primary target for the recovery of sensory function, as defined by static two-point discrimination, was fulfilled in Phase 3 pivotal research, and the safety profile was comparable with previously reported data. This information will help the company submit a Biologics License Application (BLA) in the second half of 2023.

Peripheral Nerve Injury Market Report Highlights:

  • The nerve conduit led the market and accounted for a more than 64.30% revenue share in 2024.
  • The direct nerve repair segment led the market and accounted for more than 53.26% share of the global revenue in 2024.
  • The upper extremities segment accounted for the largest market share in 2024 and is anticipated to grow further at the fastest CAGR from 2025 to 2030.
  • North America held the largest revenue share of more than 30.43% in the market in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Surgery outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Peripheral Nerve Injury Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing government fundings and reimbursements
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising medical tourism
      • 3.2.1.4. Increasing demand for 3D bioprinting approach
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness in the patients for treatment of peripheral nerve injury
      • 3.2.2.2. High cost of the treatment and unavailability of trained medical personnel
  • 3.3. Peripheral Nerve Injury Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Peripheral Nerve Injury Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Peripheral Nerve Injury Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Nerve Conduit
      • 4.5.1.1. Nerve conduit market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Nerve Protector
      • 4.5.2.1. Nerve protector market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Nerve Connector
      • 4.5.3.1. Nerve connector market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Nerve Wraps
      • 4.5.4.1. Nerve wraps market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Peripheral Nerve Injury Market: Surgery Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Surgery Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Peripheral Nerve Injury Market by Surgery Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Direct Nerve Repair
      • 5.5.1.1. Direct nerve repair market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Nerve Grafting
      • 5.5.2.1. Nerve grafting market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Stem Cell Therapy
      • 5.5.3.1. Stem cell therapy market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Peripheral Nerve Injury Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Peripheral Nerve Injury Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Upper Extremities
      • 6.5.1.1. Upper extremities market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Lower Extremities
      • 6.5.2.1. Lower extremities market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Peripheral Nerve Injury Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2024
  • 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 7.6.3. Canada
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
    • 7.6.4. Mexico
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. Mexico market estimates and forecasts, 2018 - 2030
  • 7.7. Europe
    • 7.7.1. UK
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 7.7.2. Germany
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 7.7.3. France
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 7.7.4. Italy
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 7.7.5. Spain
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 7.7.6. Denmark
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 7.7.7. Sweden
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Competitive scenario
      • 7.7.7.3. Regulatory framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 7.7.8. Norway
      • 7.7.8.1. Key country dynamics
      • 7.7.8.2. Competitive scenario
      • 7.7.8.3. Regulatory framework
      • 7.7.8.4. Reimbursement scenario
      • 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 7.8. Asia Pacific
    • 7.8.1. Japan
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 7.8.2. India
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 7.8.3. China
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 7.8.4. South Korea
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 7.8.5. Australia
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 7.8.6. Thailand
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Competitive scenario
      • 7.8.6.3. Regulatory framework
      • 7.8.6.4. Reimbursement scenario
      • 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 7.9. Latin America
    • 7.9.1. Brazil
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 7.9.2. Argentina
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Argentina market estimates and forecasts, 2018 - 2030
  • 7.10. MEA
    • 7.10.1. South Africa
      • 7.10.1.1. Key country dynamics
      • 7.10.1.2. Competitive scenario
      • 7.10.1.3. Regulatory framework
      • 7.10.1.4. Reimbursement scenario
      • 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 7.10.2. Saudi Arabia
      • 7.10.2.1. Key country dynamics
      • 7.10.2.2. Competitive scenario
      • 7.10.2.3. Regulatory framework
      • 7.10.2.4. Reimbursement scenario
      • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 7.10.3. UAE
      • 7.10.3.1. Key country dynamics
      • 7.10.3.2. Competitive scenario
      • 7.10.3.3. Regulatory framework
      • 7.10.3.4. Reimbursement scenario
      • 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 7.10.4. Kuwait
      • 7.10.4.1. Key country dynamics
      • 7.10.4.2. Competitive scenario
      • 7.10.4.3. Regulatory framework
      • 7.10.4.4. Reimbursement scenario
      • 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. AxoGen, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Stryker
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Baxter International, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Polyganics BV
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Integra LifeSciences
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Renerva, LLC.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Newrotex
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Toyobo Co., Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Orthocell Ltd
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global peripheral nerve injury market, by region 2018 - 2030 (USD Million)
  • Table 4 Global peripheral nerve injury market, by product 2018 - 2030 (USD Million)
  • Table 5 Global peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global peripheral nerve injury market, by surgery 2018 - 2030 (USD Million)
  • Table 7 North America peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America peripheral nerve injury, by application, 2018 - 2030 (USD Million)
  • Table 10 North America peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 11 U.S. peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. peripheral nerve injury, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 14 Canada peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 17 Mexico peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 20 Europe peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 24 UK peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 27 Germany peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 30 France peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 31 France peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 32 France peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 33 Italy peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 36 Spain peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 39 Sweden peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 40 Sweden peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 42 Norway peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 43 Norway peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 44 Norway peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 45 Denmark peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 47 Denmark peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 52 China peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 53 China peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 54 China peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 55 India peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 56 India peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 57 India peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 58 South Korea peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Korea peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 60 South Korea peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 61 Australia peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 64 Thailand peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 66 Thailand peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 68 Japan peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 69 Latin America peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 73 Brazil peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 76 Argentina peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa peripheral nerve injury market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 83 South Africa peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 87 South Arabia peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 89 UAE peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
  • Table 92 Kuwait peripheral nerve injury market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Peripheral nerve injury market: Market snapshot
  • Fig. 9 Peripheral nerve injury market: Market segmentation
  • Fig. 10 Peripheral nerve injury market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Peripheral nerve injury market driver impact
  • Fig. 14 Peripheral nerve injury market restraint impact
  • Fig. 15 Peripheral nerve injury market porter's five forces analysis
  • Fig. 16 Peripheral nerve injury market PESTEL analysis
  • Fig. 17 Peripheral nerve injury market segment dashboard
  • Fig. 18 Peripheral nerve injury market: Product movement Analysis
  • Fig. 19 Nerve conduit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Nerve protector market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Nerve connector market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Nerve wraps market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Peripheral nerve injury market: Surgery movement Analysis
  • Fig. 24 Direct nerve repair market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Nerve grafting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Peripheral nerve injury market: Application movement Analysis
  • Fig. 28 Upper extremities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Lower extremities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Global peripheral nerve injury market: Regional movement analysis
  • Fig. 31 Global peripheral nerve injury market: Regional outlook and key takeaways
  • Fig. 32 Global market share, by region
  • Fig. 33 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)